It develops Vonoprazan, a potassium-competitive acid blocker. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is ...
Most of the Iranian proxy's weapons storage sites and missile production facilities in its suburban Beirut stronghold have been dismantled in recent weeks, according to the IDF.